Education
About Us
Working with TipRanks
Follow Us
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
Arbutus Biopharma (ABUS) Ownership Overview
1.19% Insiders
10.63% Mutual Funds
20.25% Other Institutional Investors
10.09% ETFs
57.84% Public Companies and
Individual Investors
The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 40.97% of the company’s stock is owned by Institutional Investors, 1.19% is owned by Insiders, and 57.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 16, 2024 | Keith Manchester Director | xxxxxxxxxxxxx | $32553 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $2903737 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3177223 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,361,419 | Institution | 4.41% | 27,592,683 | |
| 7,462,935 | Institution | 3.94% | 24,627,686 | |
| 7,087,450 | Institution | 3.74% | 23,388,585 | |
| 4,244,773 | Institution | 2.24% | 14,007,751 | |
| 2,781,834 | Institution | 1.47% | 9,180,052 | |
| 1,858,391 | Institution | 0.98% | 6,132,690 | |
| 1,658,003 | Insider | 0.87% | 5,471,410 | |
| 1,608,661 | Institution | 0.85% | 5,308,581 | |
| 1,523,372 | Institution | 0.80% | 5,027,128 | |
| 971,628 | Institution | 0.51% | 3,206,372 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,087,450 | Institution | 3.74% | 23,388,585 | |
| 4,244,773 | Institution | 2.24% | 14,007,751 | |
| 2,781,834 | Institution | 1.47% | 9,180,052 | |
| 1,608,661 | Institution | 0.85% | 5,308,581 | |
| 1,523,372 | Institution | 0.80% | 5,027,128 | |
| 825,051 | Institution | 0.44% | 2,722,668 | |
| 484,841 | Institution | 0.26% | 1,599,975 | |
| 465,482 | Institution | 0.25% | 1,536,091 | |
| 418,126 | Institution | 0.22% | 1,379,816 | |
| 117,835 | Institution | 0.06% | 388,856 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,871,015 | Institution | 2.57% | 16,805,002 | |
| 3,955,784 | Institution | 2.09% | 13,054,087 | |
| 2,223,773 | Institution | 1.17% | 7,672,017 | |
| 1,533,519 | Institution | 0.81% | 5,091,283 | |
| 1,197,057 | Institution | 0.63% | 3,950,288 | |
| 894,469 | Institution | 0.47% | 2,951,748 | |
| 711,837 | Institution | 0.38% | 2,363,299 | |
| 667,200 | Institution | 0.35% | 2,301,840 | |
| 450,390 | Institution | 0.24% | 1,553,846 | |
| 329,827 | Institution | 0.17% | 1,088,429 |
FAQ
Who Owns Arbutus Biopharma Corporation (ABUS)?
According to the latest TipRanks data, approximately 20.25% of the company's stock is held by institutional investors, 1.19% is held by insiders, and 57.84% is held by retail investors.
What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.25% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.
What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.84% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.
Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?
Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.